NDC 0003-0894

ELIQUIS

Apixaban

ELIQUIS is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by E.r. Squibb & Sons, L.l.c.. The primary component is Apixaban.

Product ID0003-0894_07ff3e00-b2de-4323-b48e-46e90e682e69
NDC0003-0894
Product TypeHuman Prescription Drug
Proprietary NameELIQUIS
Generic NameApixaban
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2012-12-28
Marketing CategoryNDA / NDA
Application NumberNDA202155
Labeler NameE.R. Squibb & Sons, L.L.C.
Substance NameAPIXABAN
Active Ingredient Strength5 mg/1
Pharm ClassesFactor Xa Inhibitor [EPC],Factor Xa Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 0003-0894-21

60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0003-0894-21)
Marketing Start Date2012-12-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0003-0894-70 [00003089470]

ELIQUIS TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA202155
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2017-06-01

NDC 0003-0894-21 [00003089421]

ELIQUIS TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA202155
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-12-28

NDC 0003-0894-31 [00003089431]

ELIQUIS TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA202155
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-12-28

NDC 0003-0894-91 [00003089491]

ELIQUIS TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA202155
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-12-28

NDC 0003-0894-41 [00003089441]

ELIQUIS TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA202155
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-12-28
Marketing End Date2017-06-01

Drug Details

Active Ingredients

IngredientStrength
APIXABAN5 mg/1

OpenFDA Data

SPL SET ID:e9481622-7cc6-418a-acb6-c5450daae9b0
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1364435
  • 1992427
  • 1992428
  • 1364445
  • 1364447
  • 1364441
  • UPC Code
  • 0300030893215
  • Pharmacological Class

    • Factor Xa Inhibitor [EPC]
    • Factor Xa Inhibitors [MoA]

    NDC Crossover Matching brand name "ELIQUIS" or generic name "Apixaban"

    NDCBrand NameGeneric Name
    0003-0893ELIQUISapixaban
    0003-0894ELIQUISapixaban
    0003-3764ELIQUISapixaban
    50090-1436ELIQUISapixaban
    50090-1437ELIQUISapixaban
    55154-0612ELIQUISapixaban
    70518-1861ELIQUISELIQUIS
    55154-0613ELIQUISELIQUIS
    63629-7747ELIQUISELIQUIS
    67296-1673ELIQUISELIQUIS
    14445-149apixabanapixaban
    14445-150apixabanapixaban

    Trademark Results [ELIQUIS]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ELIQUIS
    ELIQUIS
    85544142 4451882 Live/Registered
    Bristol-Myers Squibb Company
    2012-02-16
    ELIQUIS
    ELIQUIS
    78775228 not registered Dead/Abandoned
    Pfizer Inc.
    2005-12-16
    ELIQUIS
    ELIQUIS
    77933261 not registered Dead/Abandoned
    Pfizer Inc.
    2010-02-11
    ELIQUIS
    ELIQUIS
    77933259 not registered Dead/Abandoned
    BRISTOL-MYERS SQUIBB COMPANY
    2010-02-11
    ELIQUIS
    ELIQUIS
    77933257 not registered Dead/Abandoned
    Pfizer Inc.
    2010-02-11
    ELIQUIS
    ELIQUIS
    77622324 3674414 Live/Registered
    BRISTOL-MYERS SQUIBB COMPANY
    2008-11-26
    ELIQUIS
    ELIQUIS
    76388645 3066277 Dead/Cancelled
    BRISTOL-MYERS SQUIBB COMPANY
    2002-02-26

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.